about
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive LeukemiasImpact of protein kinase CK2 inhibitors on proliferation and differentiation of neural stem cells.Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.Mammalian FMRP S499 Is Phosphorylated by CK2 and Promotes Secondary Phosphorylation of FMRP.Casein kinase 2 controls the survival of normal thymic and leukemic γδ T cells via promotion of AKT signaling.In Search of Small Molecule Inhibitors Targeting the Flexible CK2 Subunit Interface.Casein kinase: the triple meaning of a misnomer.The protein kinase 2 inhibitor CX-4945 regulates osteoclast and osteoblast differentiation in vitro.Specific inhibition of CK2α from an anchor outside the active siteProtein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo.Inhibition of CK2: An Attractive Therapeutic Target for Cancer TreatmentFunctional display of heterotetrameric human protein kinase CK2 on Escherichia coli: a novel tool for drug discoverySynthesis, Biological Evaluation and Molecular Modeling of Substituted Indeno[1,2-b]indoles as Inhibitors of Human Protein Kinase CK2.Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining.Inhibition of Protein Kinase CK2 Prevents Adipogenic Differentiation of Mesenchymal Stem Cells Like C3H/10T1/2 CellsCharacterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.A π-Halogen Bond of Dibenzofuranones with the Gatekeeper Phe113 in Human Protein Kinase CK2 Leads to Potent Tight Binding Inhibitors.Design, synthesis and biological evaluation of 2-aminopyrimidinones and their 6-aza-analogs as a new class of CK2 inhibitors.Underlying mechanisms of cyclic peptide inhibitors interrupting the interaction of CK2α/CK2β: comparative molecular dynamics simulation studies.It takes CK2 to suppress TH2.Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells
P2860
Q26769590-49E8008E-3A50-4AA1-A65E-9F5959F4B641Q33796957-C5B1C557-4D2B-499F-93B4-11F430D93287Q37247661-7A39F68D-07A1-44F9-ABC8-DE8FAAC4E3ACQ37424863-42707D16-AECA-4D38-885A-A1AB48346E7DQ37710288-52174BB9-C456-4A72-B451-E30F9A39366CQ37731316-F50D05A0-D619-45E3-8204-985F40AAC540Q38211598-D8E0B862-B7D4-4FD7-9011-73E9F8772D67Q38443998-08FBD7F6-2D12-4328-8F90-369ECE98AEF9Q38815725-0F12C4F7-614E-43FD-B4A8-684BEAB332E2Q38918816-29B32124-F50D-4151-A2F6-56E957FE6D16Q39780506-642B2910-4220-4BFD-847D-48732CEB73ADQ40876363-C428EE21-A69E-451C-A406-2103890814BCQ41416858-6D921EFB-6999-46BA-9CD4-7B0975A76B80Q42112541-E20EEB2D-F75D-4D3F-8843-7E961B1A2F01Q42293227-2A236663-7213-4136-A33A-0B0683DF7265Q43078357-8B8A7A37-ADDE-4967-856F-2F6C523E6D8FQ48170991-EE235128-8C88-48F4-8EBF-AEDD37BF1F14Q49804565-31E5978C-B811-44E2-9C03-10AEA8105FADQ54405533-8BA3834D-D614-45BE-9386-D722353C43CDQ55026799-883F2817-02D7-4046-A33A-A1ACC9B1AB7DQ55067390-6CDC1946-1C09-4EBB-A61A-E6CDFC45F689Q58572503-761A9BD9-34A8-474D-98B2-B7EC70BAFC3C
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Protein kinase CK2 inhibitors: a patent review.
@en
type
label
Protein kinase CK2 inhibitors: a patent review.
@en
prefLabel
Protein kinase CK2 inhibitors: a patent review.
@en
P2860
P50
P1476
Protein kinase CK2 inhibitors: a patent review.
@en
P2860
P304
P356
10.1517/13543776.2012.717615
P407
P577
2012-09-01T00:00:00Z